{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:40:11Z","timestamp":1792449611487,"version":"4.5.0"},"reference-count":160,"publisher":"American Chemical Society (ACS)","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"name":"Henan Provincial Soft Science Project Application","award":["252400410567"],"award-info":[{"award-number":["252400410567"]}]},{"name":"Key specialized research and development breakthrough of Henan province","award":["192102310037"],"award-info":[{"award-number":["192102310037"]}]},{"name":"Heluo Youth Talent Support Project","award":["2023HLTJ19"],"award-info":[{"award-number":["2023HLTJ19"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Triple-negative breast cancer (TNBC) is a heterogeneous type of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. Because of the lack of ER, PR, and HER2 targets, TNBC is unsuitable for endocrine therapy and HER2-targeted therapy and is associated with a higher risk of early recurrence, distant metastasis, and poorer prognosis than many other breast cancer subtypes, particularly in advanced or metastatic disease. Although surgery, chemotherapy, radiotherapy, and immunotherapy have been used for TNBC treatment, current therapeutic outcomes remain limited by systemic toxicity, high recurrence rates, insufficient tumor selectivity, and acquired drug resistance. Therefore, novel approaches are needed to address these challenges. Nanomaterials with optical, magnetic, catalytic, and porous properties can serve as imaging contrast agents, drug carriers, photosensitizers, nanozymes, radiosensitizers, and multifunctional theranostic platforms. However, the clinical translation of TNBC-oriented nanomedicines remains limited because of insufficient patient stratification, variable tumor accumulation, unclear long-term biosafety, and challenges in scalable manufacturing. To improve the clinical application of nanotechnology in TNBC treatment, it is imperative to integrate nanotechnology with existing clinical diagnosis and treatment methods. This integration may help overcome the limitations of individual diagnostic and therapeutic methods, enhance tumor targeting and radiotherapy sensitivity, reduce cytotoxicity and drug resistance, and maximize the efficiency of multimodal diagnosis and treatment.<\/jats:p>","DOI":"10.1021\/acsabm.6c01549","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:02:34Z","timestamp":1792447354000},"source":"Crossref","is-referenced-by-count":0,"title":["Nanotechnology-Based Theranostic Strategies for Triple-Negative Breast Cancer"],"prefix":"10.1021","author":[{"given":"Liufei","family":"Yang","sequence":"first","affiliation":[{"name":"Henan University of Science and Technology , , ,","place":["Luoyang, China, 471000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[{"name":"Henan University of Science and Technology , , ,","place":["Luoyang, China, 471000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Wu","sequence":"additional","affiliation":[{"name":"Henan University of Science and Technology , , ,","place":["Luoyang, China, 471000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongning","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Henan University of Science and Technology , , ,","place":["Luoyang, China, 471000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqian","family":"Zhao","sequence":"additional","affiliation":[{"name":"Henan University of Science and Technology , , ,","place":["Luoyang, China, 471000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueao","family":"Li","sequence":"additional","affiliation":[{"name":"Henan University of Science and Technology , , ,","place":["Luoyang, China, 471000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tu","sequence":"additional","affiliation":[{"name":"Henan University of Science and Technology , , ,","place":["Luoyang, China, 471000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Henan University of Science and Technology , , ,","place":["Luoyang, China, 471000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Zu","sequence":"additional","affiliation":[{"name":"Henan University of Science and Technology , , ,","place":["Luoyang, China, 471000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2070-7264","authenticated-orcid":true,"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Henan University of Science and Technology , , ,","place":["Luoyang, China, 471000"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"issue":"10286","key":"2026101918022382600_cit1","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"issue":"10074","key":"2026101918022382600_cit2","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"2026101918022382600_cit3","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"ESMO Guidelines Committee","year":"2019","journal-title":"Ann. Oncol."},{"issue":"14","key":"2026101918022382600_cit4","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100330","article-title":"Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer","volume":"38","author":"Pellacani","year":"2019","journal-title":"EMBO J."},{"issue":"9","key":"2026101918022382600_cit5","first-page":"3643","article-title":"The genetic origin of drug resistance in neoplasms: implications for systemic therapy","volume":"44","author":"Goldie","year":"1984","journal-title":"Cancer Res."},{"issue":"1","key":"2026101918022382600_cit6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/cncr.28914","article-title":"Subtyping of triple-negative breast cancer: implications for therapy","volume":"121","author":"Abramson","year":"2015","journal-title":"Cancer"},{"issue":"8","key":"2026101918022382600_cit7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41568-020-0266-x","article-title":"Key steps for effective breast cancer prevention","volume":"20","author":"Britt","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"2026101918022382600_cit8","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J. Clin."},{"issue":"6797","key":"2026101918022382600_cit9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"issue":"6","key":"2026101918022382600_cit10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3892\/ijo.2020.5135","article-title":"Triple-negative breast cancer therapy: Current and future perspectives (Review)","volume":"57","author":"Won","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"18","key":"2026101918022382600_cit11","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1002\/anie.201712027","article-title":"Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO2-Based Nanoagent to Enhance Chemodynamic Therapy","volume":"57","author":"Lin","year":"2018","journal-title":"Angew. Chem., Int. Ed."},{"issue":"18","key":"2026101918022382600_cit12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100950","article-title":"Electromagnetic Field-Programmed Magnetic Vortex Nanodelivery System for Efficacious Cancer Therapy","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci."},{"key":"2026101918022382600_cit13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jconrel.2021.04.013","article-title":"Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy","volume":"334","author":"Yang","year":"2021","journal-title":"J. Control. Release"},{"key":"2026101918022382600_cit14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jconrel.2021.07.014","article-title":"Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches","volume":"337","author":"Ghosh","year":"2021","journal-title":"J. Control. Release"},{"issue":"10","key":"2026101918022382600_cit15","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1080\/1061186X.2025.2525372","article-title":"Sacituzumab govitecan in HER2-negative breast cancer: redefining treatment paradigms","volume":"33","author":"Khadela","year":"2025","journal-title":"J. Drug Target"},{"issue":"16","key":"2026101918022382600_cit16","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"2026101918022382600_cit17","doi-asserted-by":"publisher","first-page":"13059","DOI":"10.1007\/s13277-016-5294-5","article-title":"Targeting cancer stem cell-specific markers and\/or associated signaling pathways for overcoming cancer drug resistance","volume":"37","author":"Ranji","year":"2016","journal-title":"Tumour Biol."},{"issue":"6","key":"2026101918022382600_cit18","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1158\/0008-5472.can-03-2646","article-title":"Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease","volume":"64","author":"Danna","year":"2004","journal-title":"Cancer Res."},{"issue":"6","key":"2026101918022382600_cit19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.surg.2013.02.002","article-title":"Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden","volume":"153","author":"Rashid","year":"2013","journal-title":"Surgery"},{"issue":"2","key":"2026101918022382600_cit20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/annonc\/mdr129","article-title":"Breast cancer subtypes and outcome after local and regional relapse","volume":"23","author":"Montagna","year":"2012","journal-title":"Ann. Oncol."},{"issue":"1","key":"2026101918022382600_cit21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12032-022-01922-6","article-title":"Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects","volume":"40","author":"Khadela","year":"2022","journal-title":"Med. Oncol."},{"issue":"9","key":"2026101918022382600_cit22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for Early Triple-Negative Breast Cancer","volume":"382","author":"KEYNOTE-522 Investigators","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"2026101918022382600_cit23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer","volume":"386","author":"KEYNOTE-522 Investigators","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"2026101918022382600_cit24","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1001\/jama.295.14.1658","article-title":"Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer","volume":"295","author":"Berry","year":"2006","journal-title":"JAMA"},{"key":"2026101918022382600_cit25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.critrevonc.2018.09.004","article-title":"Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies","volume":"131","author":"He","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"2026101918022382600_cit26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.clbc.2020.12.011","article-title":"Advances in Therapeutic Approaches for Triple-Negative Breast Cancer","volume":"21","author":"Breast Cancer Therapy Expert Group","year":"2021","journal-title":"Clin. Breast Cancer"},{"issue":"8","key":"2026101918022382600_cit27","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"2026101918022382600_cit28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0850-9","article-title":"Therapeutic landscape in mutational triple negative breast cancer","volume":"17","author":"Shi","year":"2018","journal-title":"Mol. Cancer"},{"issue":"20","key":"2026101918022382600_cit29","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"2026101918022382600_cit30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","article-title":"Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?","volume":"497","author":"Bai","year":"2021","journal-title":"Cancer Lett."},{"issue":"4","key":"2026101918022382600_cit31","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1158\/1078-0432.CCR-20-3646","article-title":"Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)","volume":"27","author":"Sharma","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"2026101918022382600_cit32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.annonc.2020.01.072","article-title":"Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study","volume":"31","author":"Schmid","year":"2020","journal-title":"Ann. Oncol."},{"issue":"8","key":"2026101918022382600_cit33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-059538","article-title":"Impact of homologous recombination deficiency biomarkers on outcomes in patients with early breast cancer: a systematic review protocol","volume":"12","author":"Liao","year":"2022","journal-title":"BMJ Open"},{"issue":"7","key":"2026101918022382600_cit34","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/annonc\/mdy127","article-title":"Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis","volume":"29","author":"Poggio","year":"2018","journal-title":"Ann. Oncol."},{"issue":"4","key":"2026101918022382600_cit35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.21341","article-title":"Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"14","key":"2026101918022382600_cit36","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1002\/cam4.4050","article-title":"Lumpectomy followed by radiation improves survival in HER2 positive and triple-negative breast cancer with high tumor-infiltrating lymphocytes compared to mastectomy alone","volume":"10","author":"Mouabbi","year":"2021","journal-title":"Cancer Med."},{"issue":"1","key":"2026101918022382600_cit37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups","year":"2015","journal-title":"Lancet Oncol."},{"key":"2026101918022382600_cit38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.801352","article-title":"A Comprehensive Evaluation of ZrC Nanoparticle in Combined Photothermal and Radiation Therapy for Treatment of Triple-Negative Breast Cancer","volume":"11","author":"Jiang","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"2026101918022382600_cit39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.semradonc.2004.04.008","article-title":"Tumor microenvironmental physiology and its implications for radiation oncology","volume":"14","author":"Vaupel","year":"2004","journal-title":"Semin. Radiat. Oncol."},{"issue":"9","key":"2026101918022382600_cit40","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrc1950","article-title":"Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology","volume":"6","author":"Bentzen","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"2026101918022382600_cit41","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"2026101918022382600_cit42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"2026101918022382600_cit43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","article-title":"HER2-targeted therapies - a role beyond breast cancer","volume":"17","author":"Oh","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"2026101918022382600_cit44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1056\/NEJMoa1914609","article-title":"Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer","volume":"382","author":"Murthy","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2026101918022382600_cit45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2017.07.002","article-title":"Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects","volume":"32","author":"Jia","year":"2017","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"2026101918022382600_cit46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"7","key":"2026101918022382600_cit47","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/annonc\/mdv192","article-title":"PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes","volume":"26","author":"Ali","year":"2015","journal-title":"Ann. Oncol."},{"issue":"1","key":"2026101918022382600_cit48","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/s41467-020-15364-z","article-title":"NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer","volume":"11","author":"Qin","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"2026101918022382600_cit49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-022-00601-9","article-title":"Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics","volume":"19","author":"Yamaguchi","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"2026101918022382600_cit50","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"2026101918022382600_cit51","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMc1900150","article-title":"Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer Reply","volume":"380","author":"Schmid","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"2026101918022382600_cit52","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1158\/1078-0432.CCR-22-1110","article-title":"FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer","volume":"28","author":"Shah","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"2026101918022382600_cit53","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1200\/JCO.2016.70.8297","article-title":"Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer","volume":"35","author":"Bardia","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"2026101918022382600_cit54","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12032-022-01884-9","article-title":"Unveiling the antibody-drug conjugates portfolio in battling Triple-negative breast cancer: Therapeutic trends and Future horizon","volume":"40","author":"Khadela","year":"2023","journal-title":"Med. Oncol."},{"issue":"6","key":"2026101918022382600_cit55","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"2026101918022382600_cit56","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJMoa1802905","article-title":"Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation","volume":"379","author":"Litton","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"2026101918022382600_cit57","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer","volume":"384","author":"OlympiA Clinical Trial Steering Committee and Investigators","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"2026101918022382600_cit58","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12951-022-01416-7","article-title":"All-in-one approaches for triple-negative breast cancer therapy: metal-phenolic nanoplatform for MR imaging-guided combinational therapy","volume":"20","author":"Xie","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"2026101918022382600_cit59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12951-021-00811-w","article-title":"NIR-laser-triggered gadolinium-doped carbon dots for magnetic resonance imaging, drug delivery and combined photothermal chemotherapy for triple negative breast cancer","volume":"19","author":"Jiang","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"12","key":"2026101918022382600_cit60","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.7150\/thno.74550","article-title":"Accurate programmed multifunctional nano-missiles for self-promoted deep delivery and synergistic cascade tumor therapy: Tactfully collaborating chemosynthesis with tumor microenvironment remodeling","volume":"12","author":"Lu","year":"2022","journal-title":"Theranostics"},{"issue":"23","key":"2026101918022382600_cit61","doi-asserted-by":"publisher","first-page":"8349","DOI":"10.1039\/d2nr00985d","article-title":"The strategy of precise targeting and in situ oxygenating for enhanced triple-negative breast cancer chemophototherapy","volume":"14","author":"Wu","year":"2022","journal-title":"Nanoscale"},{"issue":"42","key":"2026101918022382600_cit62","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202102527","article-title":"NIR-II Excitation Phototheranostic Nanomedicine for Fluorescence\/Photoacoustic Tumor Imaging and Targeted Photothermal-Photonic Thermodynamic Therapy","volume":"17","author":"Dai","year":"2021","journal-title":"Small"},{"issue":"10","key":"2026101918022382600_cit63","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201800382","article-title":"A Light-Triggered Mesenchymal Stem Cell Delivery System for Photoacoustic Imaging and Chemo-Photothermal Therapy of Triple Negative Breast Cancer","volume":"5","author":"Xu","year":"2018","journal-title":"Adv. Sci."},{"issue":"1","key":"2026101918022382600_cit64","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12951-022-01294-z","article-title":"Facile synthesis of near-infrared responsive on-demand oxygen releasing nanoplatform for precise MRI-guided theranostics of hypoxia-induced tumor chemoresistance and metastasis in triple negative breast cancer","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"30","key":"2026101918022382600_cit65","doi-asserted-by":"publisher","first-page":"33564","DOI":"10.1021\/acsami.0c10397","article-title":"Fibronectin-Targeting and Cathepsin B-Activatable Theranostic Nanoprobe for MR\/Fluorescence Imaging and Enhanced Photodynamic Therapy for Triple Negative Breast Cancer","volume":"12","author":"Wang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"43","key":"2026101918022382600_cit66","doi-asserted-by":"publisher","first-page":"18125","DOI":"10.1039\/d1nr05847a","article-title":"MET-targeted NIR II luminescence diagnosis and up-conversion guided photodynamic therapy for triple-negative breast cancer based on a lanthanide nanoprobe","volume":"13","author":"Wang","year":"2021","journal-title":"Nanoscale"},{"key":"2026101918022382600_cit67","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118160","article-title":"Dendronized hyaluronic acid-docetaxel conjugate as a stimuli-responsive nano-agent for breast cancer therapy","volume":"267","author":"Wang","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"11","key":"2026101918022382600_cit68","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1016\/j.bioactmat.2021.04.004","article-title":"Leukocyte\/platelet hybrid membrane-camouflaged dendritic large pore mesoporous silica nanoparticles co-loaded with photo\/chemotherapeutic agents for triple negative breast cancer combination treatment","volume":"6","author":"Zhang","year":"2021","journal-title":"Bioact. Mater."},{"key":"2026101918022382600_cit69","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bioactmat.2022.08.028","article-title":"A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody","volume":"21","author":"Li","year":"2023","journal-title":"Bioact. Mater."},{"key":"2026101918022382600_cit70","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.2147\/IJN.S380358","article-title":"Chondroitin Sulfate Targeting Nanodrug Achieves Near-Infrared Fluorescence-Guided Chemotherapy Against Triple-Negative Breast Primary and Lung Metastatic Cancer","volume":"17","author":"Huang","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"2026101918022382600_cit71","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.117459","article-title":"Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer","volume":"254","author":"Shi","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"14","key":"2026101918022382600_cit72","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1021\/acs.nanolett.1c01210","article-title":"Detachable Liposomes Combined Immunochemotherapy for Enhanced Triple-Negative Breast Cancer Treatment through Reprogramming of Tumor-Associated Macrophages","volume":"21","author":"Chen","year":"2021","journal-title":"Nano Lett."},{"issue":"3","key":"2026101918022382600_cit73","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1021\/acsnano.7b09210","article-title":"Light-Activated Core-Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast Cancer","volume":"12","author":"Meng","year":"2018","journal-title":"ACS Nano"},{"issue":"6","key":"2026101918022382600_cit74","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1021\/acs.biomac.1c00244","article-title":"Synergistic Effect of Photothermally Targeted NIR-Responsive Nanomedicine-Induced Immunogenic Cell Death for Effective Triple Negative Breast Cancer Therapy","volume":"22","author":"Yasothamani","year":"2021","journal-title":"Biomacromolecules"},{"key":"2026101918022382600_cit75","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121868","article-title":"\u201cDouble-punch\u201d strategy against triple-negative breast cancer via a synergistic therapy of magneto-mechanical force enhancing NIR-II hypothermal ablation","volume":"291","author":"Du","year":"2022","journal-title":"Biomaterials"},{"issue":"7","key":"2026101918022382600_cit76","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1021\/acs.nanolett.2c00500","article-title":"Surgical Tumor-Derived Photothermal Nanovaccine for Personalized Cancer Therapy and Prevention","volume":"22","author":"Li","year":"2022","journal-title":"Nano Lett."},{"issue":"10","key":"2026101918022382600_cit77","doi-asserted-by":"publisher","first-page":"13016","DOI":"10.1021\/acsnano.0c04375","article-title":"Suppressing the Radiation-Induced Corrosion of Bismuth Nanoparticles for Enhanced Synergistic Cancer Radiophototherapy","volume":"14","author":"Zhou","year":"2020","journal-title":"ACS Nano"},{"key":"2026101918022382600_cit78","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbac045","article-title":"Albumin-assembled copper-bismuth bimetallic sulfide bioactive nanosphere as an amplifier of oxidative stress for enhanced radio-chemodynamic combination therapy","volume":"9","author":"Tao","year":"2022","journal-title":"Regen. Biomater."},{"issue":"32","key":"2026101918022382600_cit79","doi-asserted-by":"publisher","first-page":"13681","DOI":"10.1039\/d1nr03738b","article-title":"A co-delivery nanoplatform for a lignan-derived compound and perfluorocarbon tuning IL-25 secretion and the oxygen level in tumor microenvironments for meliorative tumor radiotherapy","volume":"13","author":"Duan","year":"2021","journal-title":"Nanoscale"},{"issue":"1","key":"2026101918022382600_cit80","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1080\/10717544.2021.1995080","article-title":"Redox-sensitive iodinated polymersomes carrying histone deacetylase inhibitor as a dual-functional nano-radiosensitizer for enhanced radiotherapy of breast cancer","volume":"28","author":"Zhu","year":"2021","journal-title":"Drug Deliv."},{"issue":"39","key":"2026101918022382600_cit81","doi-asserted-by":"publisher","first-page":"16113","DOI":"10.1021\/jacs.1c06652","article-title":"Plasmonic AuPt@CuS Heterostructure with Enhanced Synergistic Efficacy for Radiophotothermal Therapy","volume":"143","author":"Cai","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"2026101918022382600_cit82","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121811","article-title":"Enhancing anti-tumor effect of ultrasensitive bimetallic RuCu nanoparticles as radiosensitizers with dual enzyme-like activities","volume":"290","author":"Hu","year":"2022","journal-title":"Biomaterials"},{"issue":"9","key":"2026101918022382600_cit83","doi-asserted-by":"publisher","first-page":"14644","DOI":"10.1021\/acsnano.2c05263","article-title":"In Situ Transformable Supramolecular Nanomedicine Targeted Activating Hippo Pathway for Triple-Negative Breast Cancer Growth and Metastasis Inhibition","volume":"16","author":"Wang","year":"2022","journal-title":"ACS Nano"},{"issue":"11","key":"2026101918022382600_cit84","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41568-020-00300-6","article-title":"Cancer progression and the invisible phase of metastatic colonization","volume":"20","author":"Klein","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"Suppl 6","key":"2026101918022382600_cit85","doi-asserted-by":"publisher","first-page":"vi23","DOI":"10.1093\/annonc\/mds191","article-title":"Imaging of triple-negative breast cancer","volume":"23","author":"Dogan","year":"2012","journal-title":"Ann. Oncol."},{"key":"2026101918022382600_cit86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109093","article-title":"Magnetic resonance imaging features for predicting axillary lymph node metastasis in patients with breast cancer","volume":"129","author":"Zhao","year":"2020","journal-title":"Eur. J. Radiol."},{"issue":"9","key":"2026101918022382600_cit87","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrcardio.2015.65","article-title":"Cardiotoxicity of anticancer treatments","volume":"12","author":"Ewer","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"issue":"16","key":"2026101918022382600_cit88","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1158\/0008-5472.CAN-18-3835","article-title":"Chromosome 12p Amplification in Triple-Negative\/BRCA1-Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity","volume":"79","author":"G\u00f3mez-Miragaya","year":"2019","journal-title":"Cancer Res."},{"issue":"14","key":"2026101918022382600_cit89","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1039\/c1sm05308f","article-title":"Biocompatible and biodegradable polymersomes for pH-triggered drug release","volume":"7","author":"Liu","year":"2011","journal-title":"Soft Matter"},{"key":"2026101918022382600_cit90","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jconrel.2020.08.045","article-title":"Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration","volume":"331","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"issue":"7 Pt B","key":"2026101918022382600_cit91","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.bbamcr.2016.01.021","article-title":"New signal transduction paradigms in anthracycline-induced cardiotoxicity","volume":"1863","author":"Ghigo","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"2026101918022382600_cit92","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.31635\/ccschem.021.202100964","article-title":"Self-Motivated Supramolecular Combination Chemotherapy for Overcoming Drug Resistance Based on Acid-Activated Competition of Host\u2013Guest Interactions","volume":"3","author":"Wang","year":"2021","journal-title":"CCS Chem."},{"issue":"2","key":"2026101918022382600_cit93","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1021\/acs.bioconjchem.8b00732","article-title":"The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery","volume":"30","author":"Smith","year":"2019","journal-title":"Bioconjugate Chem."},{"issue":"2","key":"2026101918022382600_cit94","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1021\/acsami.2c10221","article-title":"Gold Nanoparticles Functionalized with Au-Se-Bonded Peptides Used as Gatekeepers for the Off-Target Release of Resveratrol in the Treatment of Triple-Negative Breast Cancer","volume":"15","author":"Liu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"2026101918022382600_cit95","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5946\/ce.2013.46.1.24","article-title":"Photodynamic Therapy (PDT): PDT Mechanisms","volume":"46","author":"Allison","year":"2013","journal-title":"Clin. Endosc."},{"issue":"1","key":"2026101918022382600_cit96","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001926","article-title":"Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future","volume":"9","author":"Alzeibak","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"2026101918022382600_cit97","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1039\/c9cs00648f","article-title":"Multifunctional sonosensitizers in sonodynamic cancer therapy","volume":"49","author":"Son","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"9","key":"2026101918022382600_cit98","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S1470-2045(16)30224-8","article-title":"Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial","volume":"17","author":"Sultan","year":"2016","journal-title":"Lancet Oncol."},{"issue":"2","key":"2026101918022382600_cit99","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1021\/acsnano.6b08731","article-title":"Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy","volume":"11","author":"Wang","year":"2017","journal-title":"ACS Nano"},{"issue":"13","key":"2026101918022382600_cit100","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1021\/acsami.7b14603","article-title":"Theranostics of Triple-Negative Breast Cancer Based on Conjugated Polymer Nanoparticles","volume":"10","author":"Jin","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5-6","key":"2026101918022382600_cit101","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1440-1681.2006.04406.x","article-title":"Art and science of photodynamic therapy","volume":"33","author":"Pervaiz","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"7","key":"2026101918022382600_cit102","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202007017","article-title":"FAP-Targeted Photodynamic Therapy Mediated by Ferritin Nanoparticles Elicits an Immune Response against Cancer Cells and Cancer Associated Fibroblasts","volume":"31","author":"Zhou","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"2026101918022382600_cit103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105213","article-title":"Nanoparticle-based drug delivery systems for controllable photodynamic cancer therapy","volume":"144","author":"Zheng","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"2026101918022382600_cit104","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202201690","article-title":"Versatile Red Blood Cells for Triple-Negative Breast Cancer Treatment via Stepwise Photoactivations","volume":"12","author":"Cheng","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"3","key":"2026101918022382600_cit105","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/med.21771","article-title":"The role of hypoxia-inducible factor 1 in tumor immune evasion","volume":"41","author":"You","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"3","key":"2026101918022382600_cit106","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.critrevonc.2007.01.006","article-title":"Vascular endothelial growth factor (VEGF) signaling in tumor progression","volume":"62","author":"Roskoski","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"2026101918022382600_cit107","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12964-015-0118-6","article-title":"Hydrogen peroxide - production, fate and role in redox signaling of tumor cells","volume":"13","author":"Lennicke","year":"2015","journal-title":"Cell Commun. Signal"},{"key":"2026101918022382600_cit108","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.actbio.2020.05.035","article-title":"Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy","volume":"112","author":"Cheng","year":"2020","journal-title":"Acta Biomater."},{"issue":"42","key":"2026101918022382600_cit109","doi-asserted-by":"publisher","first-page":"21674","DOI":"10.1039\/d0nr05945e","article-title":"Carbon nanocage-based nanozyme as an endogenous H2O2-activated oxygenerator for real-time bimodal imaging and enhanced phototherapy of esophageal cancer","volume":"12","author":"Liu","year":"2020","journal-title":"Nanoscale"},{"issue":"11","key":"2026101918022382600_cit110","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.7150\/thno.73039","article-title":"Tumor microenvironment-activated single-atom platinum nanozyme with H2O2 self-supplement and O2-evolving for tumor-specific cascade catalysis chemodynamic and chemoradiotherapy","volume":"12","author":"Xu","year":"2022","journal-title":"Theranostics"},{"issue":"23","key":"2026101918022382600_cit111","doi-asserted-by":"publisher","first-page":"12971","DOI":"10.1002\/anie.202101924","article-title":"Single-Atom Pd Nanozyme for Ferroptosis-Boosted Mild-Temperature Photothermal Therapy","volume":"60","author":"Chang","year":"2021","journal-title":"Angew. Chem., Int. Ed."},{"issue":"2","key":"2026101918022382600_cit112","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3322\/caac.21209","article-title":"Progress and controversies: radiation therapy for invasive breast cancer","volume":"64","author":"Jagsi","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"2026101918022382600_cit113","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-016-0577-4","article-title":"Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation","volume":"16","author":"Lee","year":"2017","journal-title":"Mol. Cancer"},{"issue":"10","key":"2026101918022382600_cit114","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1039\/d0cs00718h","article-title":"Engineering nanomedicine for glutathione depletion-augmented cancer therapy","volume":"50","author":"Xiong","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"2026101918022382600_cit115","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tips.2017.11.003","article-title":"Cancer Radiosensitizers","volume":"39","author":"Wang","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"2026101918022382600_cit116","doi-asserted-by":"publisher","first-page":"9407","DOI":"10.2147\/IJN.S272902","article-title":"Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy","volume":"15","author":"Chen","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"42","key":"2026101918022382600_cit117","doi-asserted-by":"publisher","first-page":"15069","DOI":"10.1002\/anie.201906758","article-title":"NIR-II Driven Plasmon-Enhanced Catalysis for a Timely Supply of Oxygen to Overcome Hypoxia-Induced Radiotherapy Tolerance","volume":"58","author":"Yang","year":"2019","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026101918022382600_cit118","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.742215","article-title":"Hypoxia in Solid Tumors: How Low Oxygenation Impacts the \u201cSix Rs\u201d of Radiotherapy","volume":"12","author":"Rakotomalala","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"6","key":"2026101918022382600_cit119","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1021\/acs.nanolett.0c00650","article-title":"Overcoming Hypoxia-Restrained Radiotherapy Using an Erythrocyte-Inspired and Glucose-Activatable Platform","volume":"20","author":"Huang","year":"2020","journal-title":"Nano Lett."},{"issue":"6","key":"2026101918022382600_cit120","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1021\/acsnano.8b01508","article-title":"Hierarchical Multiplexing Nanodroplets for Imaging-Guided Cancer Radiotherapy via DNA Damage Enhancement and Concomitant DNA Repair Prevention","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"issue":"7","key":"2026101918022382600_cit121","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202002567","article-title":"A Robust Oxygen Microbubble Radiosensitizer for Iodine-125 Brachytherapy","volume":"8","author":"Peng","year":"2021","journal-title":"Adv. Sci."},{"issue":"6","key":"2026101918022382600_cit122","doi-asserted-by":"publisher","first-page":"9428","DOI":"10.1021\/acsnano.2c02314","article-title":"Biocompatible Tantalum Nanoparticles as Radiosensitizers for Enhancing Therapy Efficacy in Primary Tumor and Metastatic Sentinel Lymph Nodes","volume":"16","author":"Ji","year":"2022","journal-title":"ACS Nano"},{"key":"2026101918022382600_cit123","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jconrel.2022.05.018","article-title":"Dual nanoenzymes loaded hollow mesoporous organotantalum nanospheres for chemo-radio sensitization","volume":"347","author":"Peng","year":"2022","journal-title":"J. Control. Release"},{"key":"2026101918022382600_cit124","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jconrel.2022.04.033","article-title":"Rapid synthesis of 'yolk-shell'-like nanosystem for MR molecular and chemo-radio sensitization","volume":"347","author":"Hou","year":"2022","journal-title":"J. Control. Release"},{"issue":"3","key":"2026101918022382600_cit125","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1109\/TBME.2015.2466591","article-title":"Navigated Breast Tumor Excision Using Electromagnetically Tracked Ultrasound and Surgical Instruments","volume":"63","author":"Ungi","year":"2016","journal-title":"IEEE Trans. Biomed. Eng."},{"issue":"2","key":"2026101918022382600_cit126","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ejso.2020.05.025","article-title":"Navigation-assisted pelvic resections and reconstructions for periacetabular chondrosarcomas","volume":"47","author":"Fujiwara","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"issue":"14","key":"2026101918022382600_cit127","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202114722","article-title":"The Chemistry of Organic Contrast Agents in the NIR-II Window","volume":"61","author":"Mu","year":"2022","journal-title":"Angew. Chem., Int. Ed."},{"issue":"1","key":"2026101918022382600_cit128","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12951-021-01112-y","article-title":"Rapidly liver-clearable rare-earth core-shell nanoprobe for dual-modal breast cancer imaging in the second near-infrared window","volume":"19","author":"Wei","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"2026101918022382600_cit129","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1562\/2006-06-16-RA-934","article-title":"Combination of surgical resection and photodynamic therapy of 9L gliosarcoma in the nude rat","volume":"82","author":"Zhang","year":"2006","journal-title":"Photochem. Photobiol."},{"issue":"1","key":"2026101918022382600_cit130","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1038\/s41467-020-19945-w","article-title":"Upconversion NIR-II fluorophores for mitochondria-targeted cancer imaging and photothermal therapy","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"2026101918022382600_cit131","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00259-020-04978-6","article-title":"Development of [89Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer","volume":"48","author":"Cavaliere","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"2026101918022382600_cit132","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12951-022-01444-3","article-title":"Nectin-4-targeted immunoSPECT\/CT imaging and photothermal therapy of triple-negative breast cancer","volume":"20","author":"Shao","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"2026101918022382600_cit133","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jconrel.2020.09.046","article-title":"Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA-based core-crosslinked polymeric micelles","volume":"328","author":"Biancacci","year":"2020","journal-title":"J. Control. Release"},{"key":"2026101918022382600_cit134","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/IJN.S118482","article-title":"Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerations","volume":"12","author":"Santos do Carmo","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"2026101918022382600_cit135","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1148\/radiology.220.1.r01jl3113","article-title":"MR imaging of the breast for the detection, diagnosis, and staging of breast cancer","volume":"220","author":"Orel","year":"2001","journal-title":"Radiology"},{"issue":"2","key":"2026101918022382600_cit136","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1148\/radiol.2015150796","article-title":"Multicentric Cancer Detected at Breast MR Imaging and Not at Mammography: Important or Not?","volume":"279","author":"Iacconi","year":"2016","journal-title":"Radiology"},{"issue":"43","key":"2026101918022382600_cit137","doi-asserted-by":"publisher","first-page":"17025","DOI":"10.1021\/jacs.9b09149","article-title":"Molecular Magnetic Resonance Imaging with Gd(III)-Based Contrast Agents: Challenges and Key Advances","volume":"141","author":"Li","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"2026101918022382600_cit138","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s40820-020-0396-4","article-title":"Ultra-sensitive Nanoprobe Modified with Tumor Cell Membrane for UCL\/MRI\/PET Multimodality Precise Imaging of Triple-Negative Breast Cancer","volume":"12","author":"Fang","year":"2020","journal-title":"Nanomicro Lett."},{"issue":"7","key":"2026101918022382600_cit139","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1021\/acs.nanolett.1c00204","article-title":"Real-Time Intraoperative Surface-Enhanced Raman Spectroscopy-Guided Thermosurgical Eradication of Residual Microtumors in Orthotopic Breast Cancer","volume":"21","author":"Wen","year":"2021","journal-title":"Nano Lett."},{"key":"2026101918022382600_cit140","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jconrel.2021.05.013","article-title":"Decomposable black phosphorus nano-assembly for controlled delivery of cisplatin and inhibition of breast cancer metastasis","volume":"335","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"issue":"48","key":"2026101918022382600_cit141","doi-asserted-by":"publisher","first-page":"53654","DOI":"10.1021\/acsami.0c15089","article-title":"Core-Shell Nanosystems for Self-Activated Drug-Gene Combinations against Triple-Negative Breast Cancer","volume":"12","author":"Liu","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"2026101918022382600_cit142","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1021\/acs.nanolett.6b01432","article-title":"Highly Integrated Nano-Platform for Breaking the Barrier between Chemotherapy and Immunotherapy","volume":"16","author":"Zheng","year":"2016","journal-title":"Nano Lett."},{"issue":"14","key":"2026101918022382600_cit143","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143383","article-title":"Ultrasound-Mediated Cavitation Enhances EGFR-Targeting PLGA-PEG Nano-Micelle Delivery for Triple-Negative Breast Cancer Treatment","volume":"13","author":"Chen","year":"2021","journal-title":"Cancers"},{"issue":"36","key":"2026101918022382600_cit144","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1038\/s41388-018-0320-2","article-title":"LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy","volume":"37","author":"Rossow","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"2026101918022382600_cit145","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41467-020-16199-4","article-title":"Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer","volume":"11","author":"Saatci","year":"2020","journal-title":"Nat. Commun."},{"issue":"18","key":"2026101918022382600_cit146","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202100518","article-title":"A Honeycomb-Like Bismuth\/Manganese Oxide Nanoparticle with Mutual Reinforcement of Internal and External Response for Triple-Negative Breast Cancer Targeted Therapy","volume":"10","author":"Xu","year":"2021","journal-title":"Adv. Healthcare Mater."},{"issue":"8","key":"2026101918022382600_cit147","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/jbm.a.36685","article-title":"IR820-loaded PLGA nanoparticles for photothermal therapy of triple-negative breast cancer","volume":"107","author":"Valcourt","year":"2019","journal-title":"J. Biomed. Mater. Res. A"},{"key":"2026101918022382600_cit148","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121815","article-title":"Multifunctional light-activatable nanocomplex conducting temperate-heat photothermal therapy to avert excessive inflammation and trigger augmented immunotherapy","volume":"290","author":"Li","year":"2022","journal-title":"Biomaterials"},{"key":"2026101918022382600_cit149","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","article-title":"Photodynamic therapy - mechanisms, photosensitizers and combinations","volume":"106","author":"Kwiatkowski","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"2026101918022382600_cit150","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201802228","article-title":"Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy","volume":"31","author":"Chen","year":"2019","journal-title":"Adv. Mater."},{"issue":"3","key":"2026101918022382600_cit151","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.7150\/thno.67543","article-title":"Mitochondrion-targeted supramolecular \u201cnano-boat\u201d simultaneously inhibiting dual energy metabolism for tumor selective and synergistic chemo-radiotherapy","volume":"12","author":"Gao","year":"2022","journal-title":"Theranostics"},{"issue":"24","key":"2026101918022382600_cit152","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202100556","article-title":"Multifunctional Graphdiyne-Cerium Oxide Nanozymes Facilitate MicroRNA Delivery and Attenuate Tumor Hypoxia for Highly Efficient Radiotherapy of Esophageal Cancer","volume":"33","author":"Zhou","year":"2021","journal-title":"Adv. Mater."},{"issue":"7","key":"2026101918022382600_cit153","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1021\/acs.nanolett.1c04888","article-title":"DNA-Based MXFs to Enhance Radiotherapy and Stimulate Robust Antitumor Immune Responses","volume":"22","author":"Yang","year":"2022","journal-title":"Nano Lett."},{"issue":"8","key":"2026101918022382600_cit154","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201801806","article-title":"Enhanced Radiosensitization by Gold Nanoparticles with Acid-Triggered Aggregation in Cancer Radiotherapy","volume":"6","author":"Zhang","year":"2019","journal-title":"Adv. Sci."},{"issue":"4","key":"2026101918022382600_cit155","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.7150\/thno.54930","article-title":"Dual-mode endogenous and exogenous sensitization of tumor radiotherapy through antifouling dendrimer-entrapped gold nanoparticles","volume":"11","author":"Yang","year":"2021","journal-title":"Theranostics"},{"issue":"5","key":"2026101918022382600_cit156","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1021\/acsnano.8b02038","article-title":"Synergistically Enhancing the Therapeutic Effect of Radiation Therapy with Radiation Activatable and Reactive Oxygen Species-Releasing Nanostructures","volume":"12","author":"Cheng","year":"2018","journal-title":"ACS Nano"},{"issue":"7","key":"2026101918022382600_cit157","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.7150\/thno.52028","article-title":"Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"2026101918022382600_cit158","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2147\/IJN.S296513","article-title":"Combined Photothermal and Ionizing Radiation Sensitization of Triple-Negative Breast Cancer Using Triangular Silver Nanoparticles","volume":"16","author":"Sears","year":"2021","journal-title":"Int. J. Nanomedicine"},{"issue":"11","key":"2026101918022382600_cit159","doi-asserted-by":"publisher","first-page":"15161","DOI":"10.1021\/acsnano.0c05392","article-title":"An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer via Photothermal Ablation and Immune Remodeling","volume":"14","author":"Cheng","year":"2020","journal-title":"ACS Nano"},{"issue":"4","key":"2026101918022382600_cit160","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1021\/acs.nanolett.5b05030","article-title":"Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody","volume":"16","author":"Wang","year":"2016","journal-title":"Nano Lett."}],"container-title":["ACS Applied Bio Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsabm.6c01549","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aabmcb\/article-pdf\/doi\/10.1021\/acsabm.6c01549\/68907732\/mt-2026-01549j.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aabmcb\/article-pdf\/doi\/10.1021\/acsabm.6c01549\/68907732\/mt-2026-01549j.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:09:21Z","timestamp":1792447761000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aabmcb\/article\/doi\/10.1021\/acsabm.6c01549\/5453988\/Nanotechnology-Based-Theranostic-Strategies-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":160,"URL":"https:\/\/doi.org\/10.1021\/acsabm.6c01549","relation":{},"ISSN":["2576-6422"],"issn-type":[{"value":"2576-6422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]}}}